UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006518
Receipt number	R000007731
Scientific Title	Phase II study of erlotinib in advanced or recurrent EGFR mutation positive Non-small cell lung cancer patients who were previously treated with intrapleural therapy for malignant pleural effusion.
Date of disclosure of the study information	2011/10/12
Last modified on	2011/10/11 16:22:19

---